A 10-year-old child will be receiving docusate sodium (Colace), 120 mg/day PO, divided into 3 doses. How many milligrams will the child receive per dose?

A. "Continue taking OCPS because phenytoin is not safe during pregnancy."

This statement is not accurate. While it's essential to address pregnancy risk, phenytoin can reduce the effectiveness of oral contraceptives. Women on phenytoin are often advised to use additional contraceptive measures.

B. "You should use a backup method of contraception along with OCPs."

This is the correct response. Phenytoin can accelerate the metabolism of oral contraceptives, potentially reducing their effectiveness. Using a backup method, such as condoms, is recommended to ensure adequate contraception.

C. "You should stop taking OCPs because of drug-drug interactions with phenytoin."

This advice is generally not recommended without consulting the healthcare provider. Abruptly stopping OCPs without an alternative form of contraception can increase the risk of unintended pregnancy.

D. "You should take low-dose aspirin while taking these medications to reduce your risk of stroke."

This statement is not relevant to the situation described. Low-dose aspirin is not typically recommended for contraception, and its use in this context does not address the potential interaction between phenytoin and oral contraceptives.

A. Hypertension
Hypertension is not a specific concern related to the use of bisacodyl. Bisacodyl is a laxative, and high blood pressure is not typically considered a contraindication for its use.

B. Anemia
Anemia is not a specific concern related to the use of bisacodyl. The primary focus before administering bisacodyl is to assess for signs or symptoms of appendicitis, as its use is contraindicated in cases of suspected appendicitis.

C. Allergy to penicillin
Allergy to penicillin is not relevant in the context of administering bisacodyl. These are unrelated medications with different mechanisms of action, and allergy to penicillin does not impact the administration of bisacodyl.

D. Appendicitis
This is the correct choice. Before administering bisacodyl, it is crucial to assess the patient for signs or symptoms of appendicitis. The use of bisacodyl is contraindicated in cases of suspected appendicitis, as it may stimulate bowel activity and worsen the condition.